Business
Updated:

Pfizer To Buy Anacor Pharma In $5.2 Billion Deal

Pfizer Inc (PFE.N) will buy Anacor Pharmaceuticals Inc (ANAC.O) in a deal valued at $5.2 billion, net of cash, for access to Anacor’s non-steroidal topical gel to treat eczema. Pfizer will pay $99.25 per share for Anacor, a 55 percent premium to the stock’s Friday close, the companies said on Monday. REUTERS

By THEWILL_
35
0
A company logo is seen through branches at a Pfizer office in Dublin, Ireland November 24, 2015. REUTERS/Cathal McNaughton -
Latest News

Pfizer Inc (PFE.N) will buy Anacor Pharmaceuticals Inc (ANAC.O) in a deal valued at $5.2 billion, net of cash, for access to Anacor’s non-steroidal topical gel to treat eczema.

Pfizer will pay $99.25 per share for Anacor, a 55 percent premium to the stock’s Friday close, the companies said on Monday.

REUTERS

Ask ZiVA 728x90 Ads

More Articles Like This